Kamada and Chiesi Enter into a Strategic Agreement for the Distribution of Kamada's Inhaled AAT Drug for Treatment of Alpha-1 Antitrypsin Deficiency in Europe, Turkey and Former CIS Countries , Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results